BE WELL With Migraine: Brain Education and WELLness With Migraine

Exclusion Criteria

• •Major unstable medical/psychiatric condition that could be unsafe for participants or for the group environment.
• •Medication overuse headache, with migraine treatment
• •Pregnant women who are more than 16 weeks gestation at enrollment
• •Unstable migraine treatment at enrollment: any preventive treatment (oral or injectable medication or neuromodulatory device) started within 12 weeks OR acute treatment within 4 weeks to ensure stability
• •Unwillingness to maintain stable current medication dosages for study duration
• •Failure to complete baseline headache logs
• •Heavy alcohol and illicit drug use
• •Participation in another intervention clinical trial or one that would interfere in this study
• •Experience with stress reduction training (daily meditation practice, regular use of a mindfulness app, or prior experience with MBSR)
• •Any, and all other diagnoses or conditions which, in the opinion of the site investigator, would prevent the patient from being a suitable candidate for the study or interfere with the medical care needs of the study participant: COVID-positive test within 30 days of enrollment